Cognitive intervention for breast cancer patients undergoing adjuvant chemotherapy: A needs analysis

Cancer Nursing

Volumn 34, Issue 5, 2011, Pages 385-392

  Munir, Fehmidah ^a   Kalawsky, Katryna ^a   Lawrence, Catherine ^a   Yarker, Joanna ^b   Haslam, Cheryl ^a   Ahmed, Samreen ^c  

^a LOUGHBOROUGH UNIVERSITY   (United Kingdom)

^b Affinity Occupational Psychologists   (United Kingdom)

^c LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Breast cancer; Emotional distress; Intervention; Neuropsychological; Oncology; Work

Indexed keywords

CYCLOPHOSPHAMIDE; DOCETAXEL; EPIRUBICIN; FLUOROURACIL; METHOTREXATE;

ADJUVANT CHEMOTHERAPY; ADULT; ARTICLE; ATTENTION DISTURBANCE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; COGNITIVE DEFECT; EMOTIONAL STRESS; FATIGUE; HUMAN; MEMORY DISORDER; MOOD; PATIENT CARE; PRIORITY JOURNAL; QUESTIONNAIRE; SIDE EFFECT;

ADULT; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COGNITION DISORDERS; CONSUMER HEALTH INFORMATION; EMPLOYMENT; FEMALE; HUMANS; MIDDLE AGED; NEEDS ASSESSMENT; PILOT PROJECTS; QUALITATIVE RESEARCH; SOCIAL SUPPORT;

EID: 80052259230     PISSN: 0162220X     EISSN: 15389804     Source Type: Journal    
DOI: 10.1097/NCC.0b013e31820254f3     Document Type: Article

References (33)

1. Bower JE. Behavioural symptoms in patients with breast cancer and survivors. J Clin Oncol. 2008;26:768-777. (Pubitemid 351264390)
2. Falleti MG, Sanfilippo A, Maruff P, Weih L, Phillips KA. The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: A meta-analysis of the current literature. Brain Cogn. 2005;59:60-70. (Pubitemid 41405841)
3. Downie FP, Mar Fan HG, Houédé-Tchen N, Yi Q, Tannock IF. Cognitive function, fatigue, and menopausal symptoms in breast cancer patients receiving adjuvant chemotherapy: Evaluation with patient interview after formal assessment. Psychooncology. 2006;15:921-930. (Pubitemid 44612891)
4. van Dam FS, Schagen SB, Muller MJ, et al. Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: High-dose versus standard dose chemotherapy. J Natl Cancer Inst. 1998;90:210-218. (Pubitemid 28114539)
5. Lauver DR, Connolly-Nelson K, Vang P. Stressors and coping strategies among female cancer survivors after treatments. Cancer Nurs. 2007;30: 101-111. (Pubitemid 46573047)
6. Reid-Arndt SA, Hsieh C, Perry MC. Neuropsychological functioning and quality of life during the first year after completing chemotherapy for breast cancer. Psychooncology. 2009. Published online. DOI: 10.1002/ pon.1581.
7. Wefel JS, Lenzi R, Theriault RL, Davis RN, Meyers CA. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma. Cancer. 2004;100:2292-2299.
8. Nieuwenhuijsen K, de Boer A, Spelten E, Sprangers MAG, Verbeek JHAM. The role of neuropsychological functioning in cancer survivors' return to work one year after diagnosis. Psychooncology. 2009;18: 589-597.
9. Bradley CJ, Neumark D, Luo Z, Schenk M. Employment and cancer: Findings from a longitudinal study of breast and prostate cancer survivors. Cancer Invest. 2007;25:47-54. (Pubitemid 46423590)
10. Munir F, Burrows J, Yarker J, Kalawksy KEA, Bains M. Womens' perceptions of chemotherapy-induced cognitive side effects on work ability: A focus group study. Clin Nurs. 2010;19:1362-1370.
11. Gudbergsson SB, Fossa SD, Elling Borgeraas E, et al. A comparative study of living conditions in cancer patients who have returned to work after curative treatment. Support Care Cancer. 2006;14:1020-1029. (Pubitemid 44451307)
12. Amir Z, Neary D, Luker K. Cancer survivors' views of work 3 years post diagnosis: A UK perspective. Eur J Oncol Nurs. 2008;12:190-197.
13. Kennedy F, Haslam C, Munir F, Yarker J. Returning to work following cancer: A qualitative exploratory study into the experience of returning to work following cancer. Eur J Cancer Care. 2007;16:17-25.
14. Pullens MJJ, Dr Vries J, Roukema JA. Subjective cognitive dysfunction in breast cancer patients: A systematic review. Psychooncology. Published online. DOI: 10.1002/pon.1673.
15. Munir F, Yarker J, McDermott H. Employment and the common cancers: Correlates of work ability during or following cancer treatment: In-depth review. Occup Med. 2009;59:381-389.
16. Ferguson RJ, Ahles TA, Saykin Aj, et al. Cognitive-behavioral management of chemotherapy related cognitive change. Psychooncology. 2007;16: 772-777. (Pubitemid 47249179)
17. Poppelreuter M, Weis J, Bartsch HH. Effects of specific neuropsychological training programs for breast cancer patients after adjuvant chemotherapy. J Psychosoc Oncol. 2009;27:274-296.
18. Hoving JL, Broekhuizen MLA, Frings-Dresen MHW. Return to work of breast cancer survivors: A systematic review of intervention studies. BMC Cancer. 2009;9:117.
19. Broadbent DE, Cooper PF, Fitzgerald P, Parkes KR. The Cognitive Failures Questionnaire (CFQ) and its correlates. Br J Clin Psychol. 1982;21:1-16. (Pubitemid 12093480)
20. Crawford J, Parker D, McKinlay W. A Handbook of Neuropsychological Assessment. Hove: Lawrence Erlbaum Associates; 1992.
21. Jenkins V, Shilling V, Deutsch G, et al. A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer. Br J Cancer. 2006;94:828-834.
22. Shilling V, Jenkins V, Morris R, Deutsch G, Bloomfield D. The effects of adjuvant chemotherapy on cognition in women with breast cancerpreliminary results of an observational longitudinal study. Breast. 2005; 14:142-150. (Pubitemid 40353042)
23. Beck AT, Steer RA, Brown GK. Beck Depression Inventory. 2nd ed. San Antonio, TX: The Psychological Corporation; 1996.
24. Kline P. Handbook of Psychological Testing. 2nd ed. London and New York: Routledge Taylor and Francis Group; 2000.
25. Krupp LB, LaRocca NG, Muir Nash J, Steinberg A. The fatigue severity scale: Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989;46:1121-1123. (Pubitemid 19246303)
26. Hsieh HF, Shannon SE. Three approaches to qualitative content analyses. Qual Health Res. 2005;15:1277-1288. (Pubitemid 41645161)
27. Cavanagh S. Content analysis: Concepts, methods and applications. Nurs Res. 1997;4:5-16. (Pubitemid 127043282)
28. Downie-Wamboldt B. Content analysis: Method, applications and issues. Health Care Women Int. 1992;13:313-321.
29. Dasborough MT. Cognitive asymmetry in employee emotional reactions to leadership behaviours. Leadersh Q. 2006;17:163-178. (Pubitemid 43380558)
30. Narayanan L, Menon S, Spector PE. Stress in the workplace: A comparison of gender and occupations. J Org Behav. 1999;20:63-73.
31. Hermelink K, Küchenhoff H, Untch M, et al. Two different sides of 'chemobrain': Determinants and nondeterminants of self-perceived cognitive dysfunction in a prospective, randomized, multicenter study. Psychooncology. 2010. Published online. DOI: 10.1002/pon.1695.
32. Schagen SB, Das E, van Dam FSAM. The influence of priming and preexisting knowledge of chemotherapy-associated cognitive complaints on the reporting of such complaints in breast cancer patients. Psychooncology. 2009;18:674-678.
33. Brezden CB, Phillips K-A, Abdollel A, Bunston T, Tannock IF. Cognitive function in breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol. 2000;18:2695-2701. (Pubitemid 30463551)